Toronto-A team of Canadian researchers has isolated at least two unexpected strains of bacteria from the genitourinary fluids of men with type III (nonbacterial) prostatitis. The two strains, Proteobacterium species and Paenibacillus species, have never before been identified in patients with prostatitis.
Worsening economic downturn has shifted focus to helping unemployed pay for health insurance
Washington-In early September, it appeared that advocates of a new patients'
bill of rights would see success, and lobbyists for business and insurance
organizations who opposed the initiative were willing to settle for the
best deal they could get.
Seattle-Physician Micro Systems, Inc. has released Web View, a feature
allowing information contained in the company's Practice Partner Patient
Records and Appointment Scheduler to be viewed via the Internet.
In this exclusive Urology Times interview, Joseph W. Segura, MD, discusses
the current state and the future of AUA clinical practice guidelines, including
how guidelines influence practice, their use in residency training, and
upcoming guideline topics. Dr. Segura is the Carl Rosen professor of urology
at Mayo Medical School, Rochester, MN, and chairman of AUA's Practice Guidelines
Committee. The interview was conducted by UT editorial consultant Philip
M. Hanno, MD, of the department of urology, University of Pennsylvania,
Benign prostatic hyperplasia afflicts millions of men throughout the world, with an overall prevalence of histologic BPH at autopsy of 50% by age 60 years and 90% by age 85 years (J Urol 1984; 132:474-9). Surgery, although effective, includes a 1% to 3% incidence of mortality.
Salt Lake City-Varian Medical Systems, Inc., offers Eclipse, a Windows-based three-dimensional treatment planning and virtual stimulation system for cancer radiotherapy. The software features user-friendly tools for physicians to quickly identify the contours of cancerous tumors and surrounding healthy organs for more precise treatment planning, according to the company.
Dublin, Ireland-A dimethyl sulfoxide (DMSO) "cocktail" significantly improves pain and quality-of-life scores in interstitial cystitis patients, and the regimen may serve as an alternative to other instillation treatments in patients whose principal complaint is pain rather than frequency and urgency, according to researchers from Gartnavel General Hospital, Glasgow, Scotland.
Overactive bladder comprises a spectrum of conditions ranging from urgency-frequency syndrome to urge incontinence. The incidence of overactive bladder increases with age, with a prevalence exceeding 4% to 5.5% of the population. Its etiology is not clearly understood, and the treatment options often have poor efficacy and significant side effects.
Santa Barbara, CA-Mentor Corp. offers a new ergonomically designed Self-Cath Closed System for the management of urinary retention. A sterile, unisex device for individuals who must maintain an intermittent self-catheterization schedule, the system includes a pre-lubricated 100% latex-free intermittent catheter and a new, narrow collection bag.
Minimally invasive surgical approaches are an area of interest to the general public and have provided important benefits to urologic patients. The development of laparoscopic radical prostatectomy has been one of the most significant advances in the field. In this Urology Times interview, Claude C. Abbou, MD, a pioneer in laparoscopic prostatectomy, discusses the current state of the art in this cutting-edge procedure. Dr. Abbou is head of the department of urology, Hospital Henri Mondor, Creteil, France. UT Editorial Consultant Andrew C. Novick, MD, chairman of the Cleveland Clinic Urological Institute, conducted the interview.